FEK - Friedrich-Ebert-Krankenhaus Neumuenster GmbH

Neumünster 24534

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling